GeneDx Holdings (WGSWW) Net Income towards Common Stockholders Growth (1y) (2021 - 2026)
GeneDx Holdings (WGSWW) Net Income towards Common Stockholders Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | -159.32% |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 9.95% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 7.86% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 14.74% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 57.67% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | -44.49% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | -27.15% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 2.29% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | 3.59% |
| 10 | GeneDx Holdings | - | - | 68.21 Mn | -876.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -876.80% |
| Dec 31, 2025 | -425.74% |
| Sep 30, 2025 | 8.71% |
| Jun 30, 2025 | 137.05% |
| Mar 31, 2025 | 67.97% |
| Dec 31, 2024 | 121.11% |
| Sep 30, 2024 | 80.34% |
| Jun 30, 2024 | 37.56% |
| Mar 31, 2024 | 66.82% |
| Dec 31, 2023 | 91.66% |
| Sep 30, 2023 | 45.49% |
| Jun 30, 2023 | 45.51% |
| Mar 31, 2023 | 20.69% |
| Dec 31, 2022 | -668.24% |
| Sep 30, 2022 | -337.03% |
| Jun 30, 2022 | -759.05% |
| Mar 31, 2022 | 59.90% |
| Dec 31, 2021 | -0.70% |
| Sep 30, 2021 | 157.81% |
| Jun 30, 2021 | 138.08% |